<DOC>
	<DOCNO>NCT01757899</DOCNO>
	<brief_summary>The purpose study investigate effect prolong low-dose methylprednisolone infusion pulmonary function ( LIS ventilation-free day ) , extra pulmonary organ function ( PMODS score ) , inflammatory marker - RCP ( Reactive C Protein ) , IL6 ( Interleukine 6 ) , TNFα ( Tumor Necrosis Factor ) , IL8 ( Interleukine 8 ) , IL10 ( Interleukine 10 ) length Pediatric Intensive Care Unit ( PICU ) stay early ALI/ARDS child .</brief_summary>
	<brief_title>Effects Safety Infusion Low-Doses Methylprednisolone Early ALI ARDS Children</brief_title>
	<detailed_description>Scientific background . Dysregulated systemic inflammation - characterize protracted elevation inflammatory cytokine circulation - key pathogenetic mechanism morbidity mortality ALI/ARDS , associate tissue insensitivity and/or resistance inappropriately elevate endogenous glucocorticoid . In one study , prolong methylprednisolone treatment ARDS patient result rapid sustained reduction circulate pulmonary level pro-inflammatory cytokine , chemokines , procollagen . Preliminary work . Two recent metanalysis evaluate use low dos corticosteroid acute lung injury/ARDS adult report significant physiological improvement , sizable reduction duration mechanical ventilation ICU length stay reduction mortality . Hypothesis . We hypothesize prolonged administration low dose methylprednisolone pediatric ALI/ARDS safe downregulates systemic inflammation lead early resolution pulmonary extra pulmonary organ dysfunction reduction duration mechanical ventilation ICU stay . Objective . To investigate effect prolong low-dose methylprednisolone infusion pulmonary function ( LIS ventilation-free day ) , extra pulmonary organ function ( PMODS score ) , inflammatory marker - RCP ( Reactive C Protein ) , IL6 ( Interleukine 6 ) , TNFα ( Tumor Necrosis Factor ) , IL8 ( Interleukine 8 ) , IL10 ( Interleukine 10 ) length Pediatric Intensive Care Unit ( PICU ) stay early ALI/ARDS child . Study design . Prospective randomize , placebo-controlled , double-blind clinical trial .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Diagnosis ALI/ARDS within first 72 hour base follow criterion : Respiratory failure require mechanical ventilation via endotracheal intubation noninvasive positive pressure ventilation ; Acute onset bilateral pulmonary density chest radiograph context appropriate predisposing injury illness evidence leave ventricular failure ; Ratio partial pressure arterial oxygen fraction inspire oxygen ( PaO2 : FiO2 ) ≤ 300 ( criterion ALI ) 200 ( criterion ARDS ) FiO2 ≥ 0,5 PEEP = 5 cmH2O . To sign Informed Consent participate . ALI/ARDS 72 hour diagnosis Failure obtain write informed consent participate study ; Condition require &gt; 0.5mg/Kg/day prednisone equivalent ( i.e. , acute asthma bronchopulmonary dysplasia ) Patients enrol another experimental ( interventional ) protocol within past 30 day , might adversely impact result study determined investigator ; Primary secondary neuromuscular dysfunction Patients use aminoglycosides combine neuromuscular blocker Cardiopulmonary arrest within 7 day anytime present hospitalization prior enrollment ; Irreversible cessation brain function ; Immunosuppression , include HIV+ status , history bone marrow solid organ transplantation , current malignancy , neutropenia , receive cytotoxic therapy reason , acute burn injury ; Severe chronic liver disease ( ChildPugh Class C score &gt; 10 point ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>ALI</keyword>
	<keyword>Acute Lung Injury</keyword>
	<keyword>ARDS</keyword>
	<keyword>Acute Respiratory Distress Syndrome</keyword>
	<keyword>Pediatric Critical Care Medicine</keyword>
	<keyword>Inflammatory Response</keyword>
</DOC>